Loss of hepatic DRP1 exacerbates alcoholic hepatitis by inducing megamitochondria and mitochondrial maladaptation
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Background and Aims: Increased megamitochondria formation and impaired mitophagy in hepatocytes have been linked to the pathogenesis of alcohol‐associated liver disease (ALD). This study aims to determine the mechanisms by which alcohol consumption increases megamitochondria formation in the pathogenesis of ALD. Approach and Results: Human alcoholic hepatitis (AH) liver samples were used for electron microscopy, histology, and biochemical analysis. Liver‐specific dynamin‐related protein 1 (DRP1; gene name DNM1L, an essential gene regulating mitochondria fission) knockout (L‐DRP1 KO) mice and wild‐type mice were subjected to chronic plus binge alcohol feeding. Both human AH and alcohol‐fed mice had decreased hepatic DRP1 with increased accumulation of hepatic megamitochondria. Mechanistic studies revealed that alcohol feeding decreased DRP1 by impairing transcription factor EB–mediated induction of DNM1L. L‐DRP1 KO mice had increased megamitochondria and decreased mitophagy with increased liver injury and inflammation, which were further exacerbated by alcohol feeding. Seahorse flux and unbiased metabolomics analysis showed alcohol intake increased mitochondria oxygen consumption and hepatic nicotinamide adenine dinucleotide (NAD+), acylcarnitine, and ketone levels, which were attenuated in L‐DRP1 KO mice, suggesting that loss of hepatic DRP1 leads to maladaptation to alcohol‐induced metabolic stress. RNA‐sequencing and real‐time quantitative PCR analysis revealed increased gene expression of the cGAS–stimulator of interferon genes (STING)–interferon pathway in L‐DRP1 KO mice regardless of alcohol feeding. Alcohol‐fed L‐DRP1 KO mice had increased cytosolic mtDNA and mitochondrial dysfunction leading to increased activation of cGAS‐STING‐interferon signaling pathways and liver injury. Conclusion: Alcohol consumption decreases hepatic DRP1 resulting in increased megamitochondria and mitochondrial maladaptation that promotes AH by mitochondria‐mediated inflammation and cell injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
Gao, B., & Bataller, R. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.09.002 · Cited by 1,963 · cited 1×
“The pathogenesis of ALD ranges from alcoholic steatosis to alcoholic hepatitis (AH), which can progress to cirrhosis and hepatocellular carcinoma.[1,2] Because of the profound economic and health impacts of ALD,[3] a better understanding of the pathogenesis of ALD is critical for developing novel effective treatment s…”
BackgroundSelf-citationCGAS produces a 2′-5′-linked cyclic dinucleotide second messenger that activates STING.
Ablasser, A., Goldeck, M., Cavlar, T., Deimling, T., Witte, G., Röhl, I., Hopfner, K.-P., Ludwig, J., & Hornung, V. (2013) · Nature · doi:10.1038/nature12306 · Cited by 1,695 · cited 1×
“Activated cGAS increases production of secondary messenger cyclic 2′3′‐cGAMP that binds and activates stimulator of interferon (IFN) genes (STING), resulting in IFN regulatory factor (IRF)3 and IRF7 activation.[9,10] Recent evidence indicates that the cGAS‐IRF3 pathway is activated in experimental ALD models and is po…”
BackgroundDNA sensing by the cGAS–STING pathway in health and disease
Motwani, M., Pesiridis, S., & Fitzgerald, K. A. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0151-1 · Cited by 1,467 · cited 1×
“Activated cGAS increases production of secondary messenger cyclic 2′3′‐cGAMP that binds and activates stimulator of interferon (IFN) genes (STING), resulting in IFN regulatory factor (IRF)3 and IRF7 activation.[9,10] Recent evidence indicates that the cGAS‐IRF3 pathway is activated in experimental ALD models and is po…”
BackgroundChen, H., Vermulst, M., Wang, Y. E., Chomyn, A., Prolla, T. A., McCaffery, J. M., & Chan, D. C. (2010) · Cell · doi:10.1016/j.cell.2010.02.026 · Cited by 1,211 · cited 1×
“[28] Disruption of mitochondrial fusion increases mitochondrial dysfunction resulting in muscle atrophy and neurodegenerative diseases.[29,30] In contrast, inhibition of DRP1‐mediated mitochondrial fission in the liver protects against toxicant‐induced liver injury and diet‐induced NAFLD.”
BackgroundMitochondrial dynamics and mitochondrial quality control
Ni, H.-M., Williams, J. A., & Ding, W.-X. (2015) · Redox Biology · doi:10.1016/j.redox.2014.11.006 · Cited by 931 · cited 3×
“EB–mediated induction of DNM1L.”
BackgroundSelf-citationMitochondrial fusion protects against neurodegeneration in the cerebellum
Chen, H., McCaffery, J. M., & Chan, D. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.026 · Cited by 924
Alcohol and mitochondria: a dysfunctional relationship
Hoek, J. B., Cahill, A., & Pastorino, J. G. (2002) · Gastroenterology · doi:10.1053/gast.2002.33613 · Cited by 553
Mantena, S. K., King, A. L., Andringa, K. K., Eccleston, H. B., & Bailey, S. M. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.12.029 · Cited by 429
Parkin‐independent mitophagy requires Drp1 and maintains the integrity of mammalian heart and brain
Kageyama, Y., Hoshijima, M., Seo, K., Bedja, D., Sysa‐Shah, P., Andrabi, S. A., Chen, W., Höke, A., Dawson, V. L., Dawson, T. M., et al. (2014) · The EMBO Journal · doi:10.15252/embj.201488658 · Cited by 420
Self-citationChao, X., Wang, S., Zhao, K., Li, Y., Williams, J. A., Li, T., Chavan, H., Krishnamurthy, P., He, X. C., Li, L., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.05.027 · Cited by 342 · cited 5×
“[23,36,37] TFEB is a master regulator of lysosomal biogenesis, which is impaired by alcohol consumption in hepatocytes.[20] We have provided findings that TFEB also regulates mitochondria dynamics (fission) by directly regulating DRP1/ DNM1L expression.”
BackgroundInfluentialSelf-citation
Cited by
Mitochondria in oxidative stress, inflammation and aging: from mechanisms to therapeutic advances
Xu, X., Pang, Y., & Fan, X. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02253-4 · Cited by 800
Alcohol-associated liver disease
Mackowiak, B., Fu, Y., Maccioni, L., & Gao, B. (2024) · Journal of Clinical Investigation · doi:10.1172/jci176345 · Cited by 359
Liver diseases: epidemiology, causes, trends and predictions
Gan, C., Yuan, Y., Shen, H., Gao, J., Kong, X., Che, Z., Guo, Y., Wang, H., Dong, E., & Xiao, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02072-z · Cited by 310
Recent insights into the pathogenesis and therapeutic targets of chronic liver diseases
Wen, Y., Ma, L., & Ju, C. (2023) · eGastroenterology · doi:10.1136/egastro-2023-100020 · Cited by 31
Xu, H., Wu, Z., Qin, J., Li, X., Xu, F., Wang, W., Zhang, H., Yin, H., Zhu, S., Zhang, W., et al. (2025) · Gut · doi:10.1136/gutjnl-2024-334318 · Cited by 15
Metadata
- Authors
- Ma, X., Chen, A., Melo, L., Clemente‐Sanchez, A., Chao, X., Ahmadi, A. R., Peiffer, B., Sun, Z., Sesaki, H., Li, T., Wang, X., Liu, W., Bataller, R., Ni, H., & Ding, W.
- Venue
- Hepatology
- Published
- 2022-07-05
- Volume
- 77
- Issue
- 1
- Pages
- 159-175
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W4282830875
- Cited by
- 127
- References
- 11
- FWCI
- 6.91
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Loss of hepatic DRP1 exacerbates alcoholic hepatitis by inducing megamitochondria and mitochondrial maladaptation. https://app.cochat.ai/papers/10.1002/hep.32604
- The paper
- Ma, X., Chen, A., Melo, L., Clemente‐Sanchez, A., Chao, X., Ahmadi, A. R., Peiffer, B., Sun, Z., Sesaki, H., Li, T., Wang, X., Liu, W., Bataller, R., Ni, H., & Ding, W. (2023). Loss of hepatic DRP1 exacerbates alcoholic hepatitis by inducing megamitochondria and mitochondrial maladaptation. Hepatology. https://doi.org/10.1002/hep.32604
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.